TotalMarketCap

Atyr Pharma

ATYRNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$15.351 M

$6.11 -1.13%

Close of 6 Nov 2026

As of 6 Nov 2026, Atyr Pharma (ATYR) has a market capitalization of $15.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$190.0K

#3550 by revenue

Earnings

-$74.1M

Loss-making

Shares outstanding

2,549,230

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #142Jasper TherapeuticsJSPR$15.6M
  2. #143Acumen PharmaceuticalsABOS$15.4M
  3. #144Atyr PharmaATYR$15.4M
  4. #145ScilexSCLX$14.3M
  5. #146Dyadic InternationalDYAI$13.6M

What if Atyr Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$11,238,557

Per share 1,839,371× higher

Bitcoin $1.53T

$608,098.74

Per share 99,525× higher

Apple $5.02T

$1,996,331

Per share 326,732× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Atyr Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.